Late Breaking Abstract - A first-in-human study of ARO-RAGE, an RNAi therapy designed to silence pulmonary RAGE expression - Milan 2023

New mechanisms and novel insights in chronic obstructive pulmonary disease and chronic cough

Chair(s): Alexander Mathioudakis, Lies Lahousse

Session type: Oral presentation

Late Breaking Abstract - A first-in-human study of ARO-RAGE, an RNAi therapy designed to silence pulmonary RAGE expression

Mark O'Carroll

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - A first-in-human study of ARO-RAGE, an RNAi therapy designed to silence pulmonary RAGE expression

Mark O'carroll

Replay

Poster

Abstract

Slides

Inhaled Ensifentrine, decreased healthcare research utilization and reduced moderate exacerbation rate and risk in COPD over 24 Weeks

Henrik Watz

Replay

Abstract

Slides

Vitamin K status is associated with CT-quantified emphysema severity: results from COSYCONET

Ianthe Piscaer

Replay

Poster

Abstract

Slides

The effect of different inhaled corticosteroids on airway bacterial load and the microbiome in COPD: a randomized controlled trial

Hollian Richardson

Replay

Poster

Abstract

Slides

Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease.

Lies Lahousse

Replay

Poster

Abstract

Slides

Lifestyle interventions to reduce particulate matter exposure in patients with COPD

Jieun Kang

Replay

Abstract

Slides

Blood eosinophil counts in younger smokers from the Early COPD Development Partnership

Augusta Beech

Replay

Poster

Abstract

Slides

Blood eosinophil count (BEC) measured before starting inhaled corticosteroids (ICS) is better associated with treatment response to ICS in COPD.

Alexander Mathioudakis

Replay

Poster

Abstract

Slides

Improvements in Leicester Cough Questionnaire Subdomains in a Phase 2b Trial of Camlipixant in Refractory Chronic Cough

Surinder S. Birring

Replay

Poster

Abstract

Slides

Gefapixant efficacy and safety in participants with history of refractory or unexplained chronic cough for ?1 vs <1 year

Imran Satia

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}